Price target
59.080.000.00%
The 25 analysts offering 1 year price forecasts for NTLA have a max estimate of — and a min estimate of —.
Analyst rating
Based on 30 analysts giving stock ratings to NTLA in the past 3 months.
EPS
0.00
Reported
Estimate
Reported
Estimate
Surprise
Revenue
0.00
Reported
Estimate
Reported
Estimate
Surprise
This info isn't a recommendation for what you should personally do, so please don't take the data as investment advice. As with any trade, always look first, then leap. Read more in the Terms of Use.
Frequently Asked Questions
NTLA EPS for the last quarter is −1.34 USD despite the estimation of −1.39 USD. In the next quarter EPS is expected to reach −1.34 USD. Track more of Intellia Therapeutics, Inc. financials and stay on top of what is up with the company.
In the next quarter Intellia Therapeutics, Inc. revenue is expected to reach 9.28 M USD. Check out Intellia Therapeutics, Inc. revenue and earnings and make informed decisions.
According to analysts, NTLA price target is 59.08 USD with a max estimate of 128.00 USD and a min estimate of 14.00 USD. Check if this forecast comes true in a year, meanwhile watch Intellia Therapeutics, Inc. stock price chart and keep track of the current situation with NTLA news and stock market news.
We've gathered opinions of 30 analysts rating NTLA stock in the past 3 months. Most of them backed up the strong buy trend, and after taking into account other opinions, the overall rating was calculated as buy. Note that it's not a trading advice — your own analysis is still required.